Emmaus Life Sciences Receives Endari® Marketing Authorization from the Qatar Ministry of Public Health

(marketscreener.com) Company Receives First Major Purchase Order in Saudi ArabiaTORRANCE, Calif., Nov. 17, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, announced today that it has been issued a Registration Certificate from the Registration Committee for Pharmaceutical Companies & their Products of the Qatar...https://www.marketscreener.com/quote/stock/EMMAUS-LIFE-SCIENCES-INC-120797573/news/Emmaus-Life-Sciences-Receives-Endari-Marketing-Authorization-from-the-Qatar-Ministry-of-Public-Heal-42345524/?utm_medium=RSS&utm_content=20221117